Epidemiological Characteristics of Lung Cancer Patients in the Middle Euphrates Region of Iraq: Retrospective Analysis from the Middle Euphrates Cancer Center (2018-2023)

Jehan Mohammed Al-Musawi; Farah Al-Shadeedi; Nabaa Aswad Shakir; Sabreen Qasim Ibrahim

doi:10.54133/ajms.v8i2.1818

Authors

Jehan Mohammed Al-Musawi Department of Internal Medicine, College of Medicine, University of Kufa, Najaf, Iraq https://orcid.org/0000-0003-4508-0035
Farah Al-Shadeedi Middle Euphrates Cancer Center, Najaf, Iraq https://orcid.org/0009-0001-1245-3109
Nabaa Aswad Shakir Department of Radiology, Al Kindy College of Medicine, University of Baghdad, Baghdad, Iraq https://orcid.org/0000-0001-5565-0033
Sabreen Qasim Ibrahim Department of Internal Medicine, College of Medicine, University of Kufa, Najaf, Iraq https://orcid.org/0000-0002-3351-592X

DOI:

https://doi.org/10.54133/ajms.v8i2.1818

Keywords:

Epidemiology, Histopathological types, Lung cancer, Middle Euphrates region

Abstract

Background: Lung cancer is a significant public health issue in the Middle Euphrates region of Iraq. Objective: To identify socio-epidemiologic and histopathologic patterns of lung cancer patients in this region. Methods: Medical records of lung cancer patients registered at the Middle Euphrates Cancer Center (January 2018 to December 2023) were analyzed. Demographic information and histopathologic classifications were reviewed. All confirmed lung cancer cases were included, while cases with incomplete data were excluded. Results: A total of 1,162 patients were included, with a mean age at diagnosis of 64.47 years. The majority (64.4%) were over 60 years of age, and those between 40 and 60 years of age (34%). Males accounted for 68% of cases, with a male-to-female ratio of approximately 2:1. Patients with low or no formal education comprised 87.9% of the study population. The most prevalent subtype was squamous cell carcinoma (SCC), with adenocarcinoma (AC) coming in second at 37% and small cell lung cancer (SCLC) coming in third at 10.5%. While SCC remained the predominant subtype, AC incidence increased over time (31.7% in 2018 vs. 41.4% in 2023), particularly among females, younger individuals, and those with higher education. The proportion of NSCLC-NOS diagnoses declined from 11.1% in 2018 to 3.2% in 2023. Conclusions: Lung cancer remains a major health concern, especially among older individuals. The rising incidence of AC underscores the need for enhanced screening strategies, targeted prevention programs, and tailored treatment approaches to address evolving risk factors.

Downloads

Download data is not yet available.

References

Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660. DOI: https://doi.org/10.3322/caac.21660

Islami F, Torre LA, Jemal A. Global trends of lung cancer mortality and smoking prevalence. Transl Lung Cancer Res. 2015;4(4):327–338. doi: 10.3978/j.issn.2218-6751.2015.08.04.

Al-Hashimi MM, Al-Awjar MQY. Trends in lung cancer incidence in Iraq during the period 2005–2019. Int J Public Health Sci. 2024;13(3). http://doi.org/10.11591/ijphs.v13i3.23819. DOI: https://doi.org/10.11591/ijphs.v13i3.23819

Iraqi Cancer Board. Annual Report of the Iraqi Cancer Registry 2021. Baghdad: Iraqi Ministry of Health; 2022.

Anton-Culver H, Chang J, Bray F, Znaor A, Stevens L, Eser S, et al. Cancer burden in four countries of the Middle East Cancer Consortium (Cyprus; Jordan; Israel; Izmir (Turkey)) with comparison to the United States surveillance; epidemiology and end results program. Cancer Epidemiol. 2016;44:195–202. doi: 10.1016/j.canep.2016.06.004. DOI: https://doi.org/10.1016/j.canep.2016.06.004

Al-Muftah M, Al-Ejeh F. Cancer incidence and mortality estimates in Arab countries in 2018: A GLOBOCAN data analysis. Cancer Epidemiol Biomarkers Prev. 2023;32(12):1738–1744. doi: 10.1158/1055-9965.EPI-23-0520. DOI: https://doi.org/10.1158/1055-9965.EPI-23-0520

Pesch B, Kendzia B, Gustavsson P, Jöckel KH, Johnen G, Pohlabeln H, et al. Cigarette smoking and lung cancer—relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int J Cancer. 2012;131(5):1210–1219. doi: 10.1002/ijc.27339. DOI: https://doi.org/10.1002/ijc.27339

Alessy SA, Alqahtani SA, Vignat J, Abuhmaidan A, Basmi AE, Al Lawati N, et al. The current and future cancer burden in the Gulf Cooperation Council (GCC) countries. Cancer Med. 2024;13(17):e70141. doi: 10.1002/cam4.70141. DOI: https://doi.org/10.1002/cam4.70141

Salhab HA, Fares MY, Khachfe HH, Khachfe HM. Epidemiological study of lung cancer incidence in Lebanon. Medicina. 2019;55(6):217. doi: 10.3390/medicina55060217 DOI: https://doi.org/10.3390/medicina55060217

World Health Organization. WHO report on the global tobacco epidemic. Geneva: World Health Organization; 2021.

Cutler DM, Lleras-Muney A. Education and health: Evaluating theories and evidence (Working Paper No. 12352). National Bureau of Economic Research; 2006. doi: 10.3386/w1235. DOI: https://doi.org/10.3386/w12352

Jacobs-Lawson JM, Schumacher MM, Hughes T, Arnold S. The relationship between lung cancer patients' educational level and evaluation of their treatment information needs. J Cancer Educ. 2009;24(4):346-350. doi: 10.1080/08858190902876601. DOI: https://doi.org/10.1080/08858190902876601

Al-Merib FH, Obead IH. Trends characterization for rainfall time series in Middle Euphrates Region, Iraq. Ecol Eng Environ Technol. 2024;25(10):347–58. doi: 10.12912/27197050/191954. DOI: https://doi.org/10.12912/27197050/191954

Nakamura H, Saji H. A worldwide trend of increasing primary adenocarcinoma of the lung. Surg Today. 2014;44:1004–1012. doi: 10.1007/s00595-013-0636-z DOI: https://doi.org/10.1007/s00595-013-0636-z

Zhang Y, Vaccarella S, Morgan E, Li M, Etxeberria J, Chokunonga E, et al. Global variations in lung cancer incidence by histological subtype in 2020: a population-based study. Lancet Oncol. 2023;24(11):1206-1218. doi: 10.1016/S1470-2045(23)00444-8.

Cittolin-Santos GF, Knapp B, Ganesh B, Gao F, Waqar S, Stinchcombe TE, et al. The changing landscape of small cell lung cancer. Cancer. 2024;130(14):2453–2461. doi: 10.1002/cncr.35281. DOI: https://doi.org/10.1002/cncr.35281

Schabath MB, Cote ML. Cancer progress and priorities: lung cancer. Cancer Epidemiol Biomarkers Prev. 2019;28(10):1563–1579. doi: 10.1158/1055-9965.epi-19-0221. DOI: https://doi.org/10.1158/1055-9965.EPI-19-0221

Jain D, Nambirajan A, Chen G, Geisinger K, Hiroshima K, Layfield L, et al. NSCLC subtyping in conventional cytology: Results of the International Association for the Study of Lung Cancer Cytology Working Group survey to determine specific cytomorphologic criteria for adenocarcinoma and squamous cell carcinoma. J Thorac Oncol. 2022;17(6):793–805. doi: 10.1016/j.jtho.2022.02. DOI: https://doi.org/10.1016/j.jtho.2022.02.013

Zhang Y, Vaccarella S, Morgan E, Li M, Etxeberria J, Chokunonga E, et al. Global variations in lung cancer incidence by histological subtype in 2020: a population-based study. Lancet Oncol. 2023;24(11):1206–1218. doi: 10.1016/S1470-2045(23)00444-8. DOI: https://doi.org/10.1016/S1470-2045(23)00444-8

Sud A, Torr B, Jones ME, Broggio J, Scott S, Loveday C, et al. Effect of delays in the UK two-week wait cancer referral pathway during the COVID-19 pandemic on cancer survival: a modelling study. Lancet Oncol. 2020;21(8):1035–1044. doi: 10.1016/S1470-2045(20)30392-2. DOI: https://doi.org/10.1016/S1470-2045(20)30392-2

Rutter MD, Brookes M, Lee TJ, Rogers P, Sharp L. Impact of the COVID-19 pandemic on UK endoscopic activity and cancer detection: A National Endoscopy Database Analysis. Gut. 2021;70(3):537–543. doi: 10.1136/gutjnl-2020-322179. DOI: https://doi.org/10.1136/gutjnl-2020-322179

Degeling K, Baxter NN, Emery J, Cawson J, Mann GB, Vos MD. An inverse stage-shift in ductal carcinoma in situ diagnoses during the COVID-19 pandemic in Victoria, Australia. Cancer Epidemiol. 2021;71:101840. doi: 10.1016/j.canep.2020.101840. DOI: https://doi.org/10.1016/j.canep.2020.101840

Woolf SH, Chapman DA, Sabo RT, Weinberger DM, Hill L. Excess deaths from COVID-19 and other causes, March-July 2020. JAMA. 2021;324(5):510–513. doi: 10.1001/jama.2020.19545. DOI: https://doi.org/10.1001/jama.2020.11787

Govindan R, Page N, Morgensztern D, Read W, Tierney R, Vlahiotis A, et al. Changing epidemiology of small cell lung cancer in the United States over the last 30 years: analysis of the Surveillance, Epidemiologic, and End Results database. J Clin Oncol. 2006;24(28):4539–4544. doi: 10.1200/JCO.2005.04.4859. DOI: https://doi.org/10.1200/JCO.2005.04.4859

Barbeau EM, Krieger N, Soobader M-J. Working class matters: socioeconomic disadvantage, race/ethnicity, gender, and smoking in NHIS 2000. Am J Public Health. 2004;94(2):269–278. doi: 10.2105/ajph.94.2.269. DOI: https://doi.org/10.2105/AJPH.94.2.269